Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
暂无分享,去创建一个
Stewart T. Cole | Claudia Sala | Vadim Makarov | John D. McKinney | Priscille Brodin | Philip Butcher | S. Cole | S. Waddell | P. Butcher | A. Lucarelli | R. Brosch | J. Mckinney | N. Dhar | G. Manina | V. Makarov | Jana Korduláková | I. Rosenkrands | J. Grosset | J. Albrethsen | C. Sala | E. Fullam | G. Riccardi | A. Milano | S. Tyagi | U. Möllmann | K. Mikušová | O. Ryabova | M. Pasca | S. Buroni | M. Beláňová | Adela Bobovská | Petronela Dianišková | Patricia Schneider | P. Brodin | T. Christophe | V. Nandi | S. Bharath | S. Gaonkar | R. Shandil | V. Balasubramanian | T. Balganesh | Roland Brosch | Sandeep Tyagi | Jacques Grosset | Jakob Albrethsen | Thierry Christophe | Neeraj Dhar | Ute Möllmann | Sheshagiri Gaonkar | Sowmya Bharath | Elizabeth Fullam | Giulia Manina | Patricia Schneider | Giovanna Riccardi | Edda De Rossi | Ida Rosenkrands | Anna Milano | Maria Rosalia Pasca | Silvia Buroni | Katarina Mikusova | Olga Ryabova | Brigitte Saint-Joanis | Anna Paola Lucarelli | Martina Belanova | Adela Bobovska | Petronela Dianiskova | Jana Kordulakova | Simon Waddell | Vrinda Nandi | Radha K. Shandil | Venkataraman Balasubramanian | Tanjore Balganesh | E. De Rossi | B. Saint‐Joanis
[1] G. Besra,et al. Deletion of Cg-emb in Corynebacterianeae Leads to a Novel Truncated Cell Wall Arabinogalactan, whereas Inactivation of Cg-ubiA Results in an Arabinan-deficient Mutant with a Cell Wall Galactan Core* , 2005, Journal of Biological Chemistry.
[2] M. Matsumoto,et al. OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice , 2006, PLoS medicine.
[3] Michael Z. Lin,et al. Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome , 2009, Science.
[4] G. Besra,et al. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol , 1995, Antimicrobial agents and chemotherapy.
[5] J. Norton,et al. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] Mehran Hosseini,et al. Global incidence of multidrug-resistant tuberculosis. , 2006, The Journal of infectious diseases.
[7] Pedro M Alzari,et al. Rising standards for tuberculosis drug development. , 2008, Trends in pharmacological sciences.
[8] T. Myers,et al. The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism , 2004, Journal of Biological Chemistry.
[9] P. Zipfel,et al. Synthesis and antileprosy activity of some dialkyldithiocarbamates. , 2006, The Journal of antimicrobial chemotherapy.
[10] Pilho Kim,et al. PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release , 2008, Science.
[11] Hinrich W. H. Göhlmann,et al. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.
[12] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[13] Jun Liu. Tuberculosis and the Tubercle Bacillus , 2005, Emerging Infectious Diseases.
[14] Stewart T. Cole,et al. Tuberculosis and the tubercle bacillus. , 2005 .
[15] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[16] P. Brennan,et al. Decaprenylphosphoryl Arabinofuranose, the Donor of the d-Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose , 2005, Journal of bacteriology.
[17] B. Wolucka,et al. Biosynthesis of D‐arabinose in mycobacteria – a novel bacterial pathway with implications for antimycobacterial therapy , 2008, The FEBS journal.
[18] D Fenistein,et al. A fast, fully automated cell segmentation algorithm for high‐throughput and high‐content screening , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[19] E. Rubin,et al. Comprehensive identification of conditionally essential genes in mycobacteria , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Leibler,et al. Bacterial Persistence as a Phenotypic Switch , 2004, Science.
[21] P. Brennan. Foreword from the Co-Editor-in-Chief , 2001 .
[22] M. Perkins,et al. Confronting the scientific obstacles to global control of tuberculosis. , 2008, The Journal of clinical investigation.
[23] Clifton E. Barry,et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis , 2000, Nature.
[24] Neel R Gandhi,et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2006, The Lancet.
[25] D. L. Taylor,et al. High content screening applied to large-scale cell biology. , 2004, Trends in biotechnology.
[26] C. Dye. Global epidemiology of tuberculosis , 2006, The Lancet.
[27] S. Waddell,et al. Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis. , 2007, Current molecular medicine.